CN107840820A - A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines - Google Patents

A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines Download PDF

Info

Publication number
CN107840820A
CN107840820A CN201711140717.6A CN201711140717A CN107840820A CN 107840820 A CN107840820 A CN 107840820A CN 201711140717 A CN201711140717 A CN 201711140717A CN 107840820 A CN107840820 A CN 107840820A
Authority
CN
China
Prior art keywords
morpholine
bases
pyridine
reaction
fluorine pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711140717.6A
Other languages
Chinese (zh)
Inventor
黄筑艳
乐意
刘力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou University
Original Assignee
Guizhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guizhou University filed Critical Guizhou University
Priority to CN201711140717.6A priority Critical patent/CN107840820A/en
Publication of CN107840820A publication Critical patent/CN107840820A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals

Abstract

The invention discloses a kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines.Comprise the steps of:(1) using the nitropyridine of 2 chlorine 3 as raw material, reaction 4 (base of 3 nitropyridine 2) morpholines of generation are substituted;(2) 4 (base of 3 nitropyridine 2) morpholines generate the amine of 2 morpholino pyridine 3 through reduction reaction;The amine of (3) 2 morpholino pyridine 3 generates 4 (base of 3 fluorine pyridine 2) morpholines through diazotising and substitution reaction;(4) 4 (base of 3 fluorine pyridine 2) morpholines are substituted reaction and obtain target compound 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholine.This route raw material is cheap and easy to get, and operating condition is gently easily-controllable, and product is advantageous to practical application compared with easy purification.

Description

A kind of preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
Technical field
The present invention relates to a kind of preparation technology of new 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine.Belong to organic synthesis, Fine chemistry industry, medicine intermediate field.
Background technology
Compound containing pyridine ring and the compound of the ring containing morpholine are the important source materials of chemical industry, are widely used in curing Medicine intermediate, pharmaceutical products, agricultural chemicals, pesticide intermediate, feed and feedstuff and other multiple fields.4- (the bromo- 3- fluorine pyrroles of 5- Pyridine -2- bases) contain pyridine ring and morpholine ring in morpholine molecule, while can also pass through coupling containing the halogen atom easily to react Reaction etc. chemically reacts into target molecule while introduces pyridine ring and morpholine ring, thus is widely used in GPR40 receptor activations The building-up process of the medicines such as agent, LSD1 inhibitor, Syk inhibitor.
The synthetic route on 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine has following several at present:
WO2010143733 report using the fluoro- 5- bromopyridines of the chloro- 3- of 2- as raw material, with morpholine under 210 DEG C of high temperature microwave Reaction generation 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine.This route is raw materials used more expensive, also needs to use microwave reactor, and grasp It is higher to make temperature, is unfavorable for commercial Application.
The route of WO2016007731 reports, with bromo- 2, the 3- difluoro pyridines of 5- for raw material, reacts 12 at room temperature with morpholine Individual hour generates 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine.This route is raw materials used costly, the difficult separation of accessory substance, is unfavorable for Commercial Application.
The content of the invention
The technical problem to be solved in the present invention is:A kind of system of new 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine is provided Standby technique.Solves in the prior art the problem of cost of material is higher, and operating condition requirement is higher.
Technical scheme:A kind of preparation method of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine, including:(1) with The chloro- 3- nitropyridines of 2- are raw material, are substituted reaction generation 4- (3- nitropyridine -2- bases) morpholine;(2) 4- (3- nitro pyrroles Pyridine -2- bases) morpholine through reduction reaction generate 2- morpholino pyridine -3- amine;(3) 2- morpholinoes pyridine -3- amine through diazotising and takes Generation reaction generation 4- (3- fluorine pyridine -2- bases) morpholine;(4) 4- (3- fluorine pyridine -2- bases) morpholine is substituted reaction and obtains targeted Compound 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine.
(1) the step reaction solvent for use is:DMF or DMSO;Acid binding agent is:Potassium carbonate, sodium carbonate, sodium acid carbonate or Triethylamine;Substitution reagent be:Morpholine;Reaction temperature is: 85℃;Reaction time is:6~8h;Acid binding agent and the chloro- 3- nitros of 2- The molar ratio of pyridine is:1:1~3:1;Substitution reagent and the chloro- 3- nitropyridines of 2- molar ratio be:1:1~2:1.
(2) the step reaction solvent for use is:Methanol, ethanol or acetone;Catalyst is:Palladium carbon;Reducing agent is:Hydrogen Gas;Reaction temperature is:Room temperature;Reaction time is:10~16h;The matter that feeds intake of catalyst and 4- (3- nitropyridine -2- bases) morpholine Measuring ratio is:1:100~1:10.
(3) step reaction is that 1eq 2- morpholino pyridine -3- amine is dissolved in into 1~5eq hydrogen fluoride pyrrole at 0 DEG C In pyridine, 1~2eq natrium nitrosum, insulation reaction 0.5-1h, then 50 DEG C of 1~3h of back flow reaction are added.
(4) the step reaction solvent for use is:DMF or acetonitrile;Substitution reagent be:NBS;Reaction temperature is:50~80 ℃;Reaction time is:1~2h;Substitution reagent and 4- (3- fluorine pyridine -2- bases) morpholine molar ratio be:1:1~1:2.
Beneficial effects of the present invention:The present invention synthesizes target using the chloro- 3- nitropyridines of 2- as initiation material, through four-step reaction Compound.This route raw material is cheap and easy to get, and operating condition is gently easily-controllable, and product is advantageous to practical application compared with easy purification.
Embodiment
Embodiment 1
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), addition potassium carbonate (52.3g, 378.5mmol), morpholine (13.2g, 151.4 mmol), 85 DEG C of reaction 7h are slowly added to.Reaction finishes, and is cooled to room temperature, adds 200mL pure water, ethyl acetate (200mL × 2) extraction, collects organic phase, anhydrous sodium sulfate drying, filters out solid, evaporated under reduced pressure Solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow solid, is obtained 21.2g, yield 80.3%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (11.0g, 52.6mmol) is dissolved in methanol (100mL), adds 10% Palladium carbon (1.1g, 1.1mmol), be passed through hydrogen, react at room temperature 14h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 8.3g, are obtained, are received Rate is 88.0%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (35mL), Natrium nitrosum (2.7g, 39.1mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 1h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.6g, yield 65.2%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (3.0g, 16.5mmol) is dissolved in DMF (30mL), is slowly added to NBS (2.9g, 16.5mmol), 80 DEG C of reaction 1h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 3.9g, yield 90.7%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 2
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMSO (160mL), add potassium carbonate (34.9g, 252.3mmol), it is slowly added to morpholine (13.2g, 151.4 mmol), 85 DEG C of reaction 7h.Reaction finishes, and is cooled to room Temperature, 200mL pure water is added, ethyl acetate (200mL × 2) extraction, organic phase is collected, anhydrous sodium sulfate drying, filters out solid, subtract Solvent evaporated is pressed, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow, is obtained to consolidate Body 21.0g, yield 79.4%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (10.0g, 47.8mmol) is dissolved in methanol (100mL), adds 10% Palladium carbon (1.0g, 1.0mmol), be passed through hydrogen, react at room temperature 14h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 7.5g, are obtained, are received Rate is 87.4%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (18mL), Natrium nitrosum (2.7g, 39.1mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 3h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.5g, yield 63.4%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (4.0g, 22.0mmol) is dissolved in DMF (40mL), is slowly added to NBS (3.9g, 22.0mmol), 80 DEG C of reaction 1h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 5.2g, yield 90.1%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 3
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), addition sodium carbonate (40.1g, 378.5mmol), morpholine (16.5g, 189.2 mmol), 85 DEG C of reaction 6h are slowly added to.Reaction finishes, and is cooled to room temperature, adds 200mL pure water, ethyl acetate (200mL × 2) extraction, collects organic phase, anhydrous sodium sulfate drying, filters out solid, evaporated under reduced pressure Solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow solid, is obtained 21.7g, yield 82.1%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (10.0g, 47.8mmol) is dissolved in ethanol (100mL), adds 10% Palladium carbon (1.0g, 1.0mmol), be passed through hydrogen, react at room temperature 14h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 7.6g, are obtained, are received Rate is 88.6%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (53mL), Natrium nitrosum (2.7g, 39.1mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 2h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.8g, yield 67.7%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (4.0g, 22.0mmol) is dissolved in DMF (40mL), is slowly added to NBS (3.9g, 22.0mmol), 80 DEG C of reaction 1h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 5.3g, yield 91.5%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 4
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), add sodium acid carbonate (31.8g, 378.5mmol), it is slowly added to morpholine (13.2g, 151.4mmol), 85 DEG C of reaction 8h.Reaction finishes, and is cooled to room Temperature, 200mL pure water is added, ethyl acetate (200mL × 2) extraction, organic phase is collected, anhydrous sodium sulfate drying, filters out solid, subtract Solvent evaporated is pressed, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow, is obtained to consolidate Body 20.5g, yield 77.6%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (10.0g, 47.8mmol) is dissolved in acetone (100mL), adds 10% Palladium carbon (1.0g, 1.0mmol), be passed through hydrogen, react at room temperature 14h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 7.4g, are obtained, are received Rate is 86.7%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (53mL), Natrium nitrosum (5.4g, 78.1mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 1h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.8g, yield 67.1%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (3.0g, 16.5mmol) is dissolved in DMF (30mL), is slowly added to NBS (4.4g, 24.7mmol), 70 DEG C of reaction 1h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 3.8g, yield 89.1%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 5
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), addition triethylamine (38.3g, 378.5mmol), morpholine (13.2g, 151.4 mmol), 85 DEG C of reaction 8h are slowly added to.Reaction finishes, and is cooled to room temperature, adds 200mL pure water, ethyl acetate (200mL × 2) extraction, collects organic phase, anhydrous sodium sulfate drying, filters out solid, evaporated under reduced pressure Solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow solid, is obtained 20.2g, yield 76.6%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (10.0g, 47.8mmol) is dissolved in methanol (100mL), adds 10% Palladium carbon (0.5g, 0.5mmol), be passed through hydrogen, react at room temperature 16h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 7.4g, are obtained, are received Rate is 86.0%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (35mL), Natrium nitrosum (4.0g, 58.6mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 1h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.7g, yield 65.8%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (3.0g, 16.5mmol) is dissolved in DMF (30mL), is slowly added to NBS (3.8g, 21.4mmol), 80 DEG C of reaction 1h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 4.0g, yield 91.9%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 6
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), addition potassium carbonate (17.4g, 126.2mmol), morpholine (11.0g, 126.2 mmol), 85 DEG C of reaction 8h are slowly added to.Reaction finishes, and is cooled to room temperature, adds 200mL pure water, ethyl acetate (200mL × 2) extraction, collects organic phase, anhydrous sodium sulfate drying, filters out solid, evaporated under reduced pressure Solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow solid, is obtained 20.7g, yield 78.3%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (11.0g, 52.6mmol) is dissolved in methanol (100mL), adds 10% Palladium carbon (5.6g, 5.3mmol), be passed through hydrogen, react at room temperature 10h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 8.5g, are obtained, are received Rate is 90.1%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (35mL), Natrium nitrosum (3.2g, 46.9mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 1h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.7g, yield 66.6%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (3.0g, 16.5mmol) is dissolved in DMF (30mL), is slowly added to NBS (2.9g, 16.5mmol), 65 DEG C of reaction 2h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 3.8g, yield 87.1%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 7
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), addition potassium carbonate (34.9g, 252.3mmol), morpholine (16.5g, 189.2 mmol), 85 DEG C of reaction 7h are slowly added to.Reaction finishes, and is cooled to room temperature, adds 200mL pure water, ethyl acetate (200mL × 2) extraction, collects organic phase, anhydrous sodium sulfate drying, filters out solid, evaporated under reduced pressure Solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow solid, is obtained 21.4g, yield 81.1%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (11.0g, 52.6mmol) is dissolved in methanol (100mL), adds 10% Palladium carbon (2.8g, 2.6mmol), be passed through hydrogen, react at room temperature 12h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 8.5g, are obtained, are received Rate is 89.7%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (35mL), Natrium nitrosum (3.5g, 50.8mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 1h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.7g, yield 66.1%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (3.0g, 16.5mmol) is dissolved in DMF (30mL), is slowly added to NBS (5.9g, 32.9mmol), 80 DEG C of reaction 1h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 4.0g, yield 93.1%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。
Embodiment 8
A.4- the preparation of (3- nitropyridine -2- bases) morpholine
The chloro- 3- nitropyridines (20.0g, 126.2mmol) of 2- are dissolved in DMF (160mL), addition potassium carbonate (52.3g, 378.5mmol), morpholine (22.0g, 252.3 mmol), 85 DEG C of reaction 6h are slowly added to.Reaction finishes, and is cooled to room temperature, adds 200mL pure water, ethyl acetate (200mL × 2) extraction, collects organic phase, anhydrous sodium sulfate drying, filters out solid, evaporated under reduced pressure Solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 4- (3- nitropyridine -2- bases) morpholine yellow solid, is obtained 21.7g, yield 82.2%.
B.2- the preparation of morpholino pyridine -3- amine
4- (3- nitropyridine -2- bases) morpholine (11.0g, 52.6mmol) is dissolved in methanol (100mL), adds 10% Palladium carbon (1.7g, 1.6mmol), be passed through hydrogen, react at room temperature 14h.Reaction finishes, and removes solvent, residue water under reduced pressure (100mL) dissolves, ethyl acetate (100 mL × 3) extraction, collects organic phase, and anhydrous sodium sulfate drying filters out solid, and decompression is steamed Dry solvent, residue cross silicagel column (mobile phase PE:EA=10:1) 2- morpholino pyridine -3- amine gray solid 8.4g, are obtained, are received Rate is 89.6%.
C.4- the preparation of (3- fluorine pyridine -2- bases) morpholine
Below 0 DEG C, 2- morpholino pyridine -3- amine (7.0g, 39.1mmol) is dissolved in hydrogen fluoride pyridine (35mL), Natrium nitrosum (2.7g, 39.1mmol), insulation reaction 30min are slowly added to, then 50 DEG C of back flow reaction 3h, reaction finishes, and falls Enter in ice, it is anhydrous to alkalescence, ethyl acetate (100mL × 3) extraction, collection organic phase to adjust pH value with saturated sodium carbonate solution Sodium sulphate is dried, and filters out solid, evaporated under reduced pressure solvent, residue crosses silicagel column (mobile phase PE:EA=10:1) 4- (3- fluorine, is obtained Pyridine -2- bases) morpholine yellow liquid 4.7g, yield 65.8%.
D.4- the preparation of (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine
4- (3- fluorine pyridine -2- bases) morpholine (3.0g, 16.5mmol) is dissolved in DMF (30mL), is slowly added to NBS (4.4g, 24.7mmol), 50 DEG C of reaction 2h.Reaction finishes, and adds 50mL pure water, ethyl acetate (50mL × 3) extraction, and collection has Machine phase, anhydrous sodium sulfate drying filter out solid, evaporated under reduced pressure solvent, and residue crosses silicagel column (mobile phase PE:EA=10:1), Obtain 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine yellow solid 3.7g, yield 86.9%.
1H NMR(400MHz,CDCl3)δ8.05(s,1H),7.37-7.41(d,1H),3.81 -3.84(m,4H),3.45- 3.47(m,4H)。

Claims (6)

  1. A kind of 1. preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine, it is characterised in that:Comprise the steps of:(1) with The chloro- 3- nitropyridines of 2- are raw material, are substituted reaction generation 4- (3- nitropyridine -2- bases) morpholine;(2) 4- (3- nitropyridines- 2- yls) morpholine through reduction reaction generate 2- morpholino pyridine -3- amine;(3) 2- morpholinoes pyridine -3- amine is anti-through diazotising and substitution 4- (3- fluorine pyridine -2- bases) morpholine should be generated;(4) 4- (3- fluorine pyridine -2- bases) morpholine is substituted reaction and obtains target compound 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine.
  2. A kind of 2. preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine according to claim 1, it is characterised in that: Intermediate is 4- (3- nitropyridine -2- bases) morpholine, 2- morpholinoes pyridine -3- amine and 4- (3- fluorine pyridine -2- bases) morpholine.
  3. A kind of 3. preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine according to claim 1, it is characterised in that: (1) the step reaction solvent for use is:DMF or DMSO;Acid binding agent is:Potassium carbonate, sodium carbonate, sodium acid carbonate or triethylamine; Substitution reagent be:Morpholine;Reaction temperature is:85℃;Reaction time is:6~8h;The throwing of acid binding agent and the chloro- 3- nitropyridines of 2- Expect that mol ratio is:1:1~3:1;Substitution reagent and the chloro- 3- nitropyridines of 2- molar ratio be:1:1~2:1.
  4. A kind of 4. preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine according to claim 1, it is characterised in that: (2) the step reaction solvent for use is:Methanol, ethanol or acetone;Catalyst is:Palladium carbon;Reducing agent is:Hydrogen;Reaction temperature Spend and be:Room temperature;Reaction time is:10~16h;The mass ratio that feeds intake of catalyst and 4- (3- nitropyridine -2- bases) morpholine is:1: 100~1:10.
  5. A kind of 5. preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine according to claim 1, it is characterised in that: (3) step reaction is that 1eq 2- morpholino pyridine -3- amine is dissolved in 1~5eq hydrogen fluoride pyridine below 0 DEG C, adds 1 ~2eq natrium nitrosum, insulation reaction 0.5-1h, then 50 DEG C of back flow reactions.
  6. A kind of 6. preparation technology of 4- (the bromo- 3- fluorine pyridine -2- bases of 5-) morpholine according to claim 1, it is characterised in that: (4) step reaction solvent for use is:DMF or acetonitrile;Substitution reagent be:NBS;Reaction temperature is:50~80 DEG C;Substitute reagent with The molar ratio of 4- (3- fluorine pyridine -2- bases) morpholine is:1:1~1:2.
CN201711140717.6A 2017-11-16 2017-11-16 A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines Pending CN107840820A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711140717.6A CN107840820A (en) 2017-11-16 2017-11-16 A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711140717.6A CN107840820A (en) 2017-11-16 2017-11-16 A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines

Publications (1)

Publication Number Publication Date
CN107840820A true CN107840820A (en) 2018-03-27

Family

ID=61679713

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711140717.6A Pending CN107840820A (en) 2017-11-16 2017-11-16 A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines

Country Status (1)

Country Link
CN (1) CN107840820A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111777549A (en) * 2020-07-07 2020-10-16 中瀚(齐河县)生物医药科技有限公司 Synthesis process of 2-methoxy-3-bromo-5-fluoropyridine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103214481A (en) * 2012-01-21 2013-07-24 中国科学院上海药物研究所 Novel imidazo[1,2-a]pyridines compound, preparation method, pharmaceutical composition containing imidazo[1,2-a]pyridines compound and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103214481A (en) * 2012-01-21 2013-07-24 中国科学院上海药物研究所 Novel imidazo[1,2-a]pyridines compound, preparation method, pharmaceutical composition containing imidazo[1,2-a]pyridines compound and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAVID A. CLARK等: "Synthesis of insecticidal fluorinated anthranilic diamides", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *
PATRICIA A. PIEPER等: "3-deoxy-3-fluoropyridoxamine 5-phosphate:Synthesis and Chemical and Biological Properties of a Coenzyme B6 Analog", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111777549A (en) * 2020-07-07 2020-10-16 中瀚(齐河县)生物医药科技有限公司 Synthesis process of 2-methoxy-3-bromo-5-fluoropyridine

Similar Documents

Publication Publication Date Title
CN104610250B (en) 1,2,3-thiadiazole-5-formamidine compound containing three N-heterocycles and synthesis
CN112679420B (en) Preparation method of 2,5-dibromopyridine
CN104250232A (en) Preparation method of parecoxib sodium
CN109280026A (en) A kind of preparation method of 2,3- dichloropyridine
CN110903248B (en) Synthesis method of 5-chloro-4-aminopyridazine
CN107840820A (en) A kind of preparation technology of 4 (base of 5 bromine, 3 fluorine pyridine 2) morpholines
CN110845401B (en) Synthesis method of 2-fluoro-3, 6-dihydroxypyridine
CN105272987B (en) A kind of preparation method of 3 cyano group N dislocation porphyrin compound
CN113620868A (en) Torasemide new impurity and preparation method thereof
CN105367481B (en) A kind of synthetic method of bis- fluoro- 2- oxoindole derivatives of 3,3-
CN110885291B (en) Synthetic method of 3-chloro-5- (difluoromethoxy) benzylamine
CN111592481B (en) Preparation method of polysubstituted pyrroline compound
CN105001163B (en) A kind of synthetic method of four substituted imidazoles
CN103539728A (en) Synthesis method of lansoprazole drug intermediate chloromethyl pyridine derivative
CN104163798A (en) Synthesis method of 3-amino-8-trifluoromethyl quinoline
CN111285798A (en) Synthesis method of (3-cyclopropylpyridine-2-yl) methylamine hydrochloride
CN114349690B (en) Synthesis method of doravirine intermediate
CN103265479B (en) A kind of synthetic method of the 6 chloromethyl nicotinic acid tert-butyl ester
CN109438451A (en) The method of level-one amine guiding building 6- (2- bromophenyl) indoles simultaneously [1,2-a] quinoxaline
CN107698500A (en) A kind of preparation method of Netupitant
CN113549009B (en) Industrial synthesis method of 2,3-dichloropyridine
CN111848430B (en) Synthetic method of 2- ([ 1,1' -biphenyl ] -4-yl) -2-glycine compound
CN116102440A (en) Preparation method of 1- (3, 4-diaminophenyl) ethanone
CN105693635B (en) The method that carboxymethyl cellulose copper (II) catalyzes and synthesizes 1,2,3- triazole compound
CN109627246A (en) The method of level-one amine guiding building 7- methyl -6- Phenylindole simultaneously [1,2-a] quinoxaline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180327

RJ01 Rejection of invention patent application after publication